310 related articles for article (PubMed ID: 11991532)
1. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
Pizarro N; Ortuño J; Farré M; Hernández-López C; Pujadas M; Llebaria A; Joglar J; Roset PN; Mas M; Segura J; Camí J; de la Torre R
J Anal Toxicol; 2002 Apr; 26(3):157-65. PubMed ID: 11991532
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
[TBL] [Abstract][Full Text] [Related]
3. Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.
Pirnay SO; Abraham TT; Huestis MA
Clin Chem; 2006 Sep; 52(9):1728-34. PubMed ID: 16858076
[TBL] [Abstract][Full Text] [Related]
4. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
Kolbrich EA; Lowe RH; Huestis MA
Clin Chem; 2008 Feb; 54(2):379-87. PubMed ID: 18089653
[TBL] [Abstract][Full Text] [Related]
5. Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
da Silva DG; de Pinho PG; Pontes H; Ferreira L; Branco P; Remião F; Carvalho F; Bastos ML; Carmo H
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):815-22. PubMed ID: 20167546
[TBL] [Abstract][Full Text] [Related]
6. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.
Pizarro N; Llebaria A; Cano S; Joglar J; Farré M; Segura J; de la Torre R
Rapid Commun Mass Spectrom; 2003; 17(4):330-6. PubMed ID: 12569443
[TBL] [Abstract][Full Text] [Related]
7. Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
Valtier S; Phelix CF; Cody JT
J Anal Toxicol; 2007 Apr; 31(3):138-43. PubMed ID: 17579960
[TBL] [Abstract][Full Text] [Related]
8. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
Abraham TT; Barnes AJ; Lowe RH; Kolbrich Spargo EA; Milman G; Pirnay SO; Gorelick DA; Goodwin RS; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650
[TBL] [Abstract][Full Text] [Related]
9. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
Shima N; Kamata H; Katagi M; Tsuchihashi H; Sakuma T; Nemoto N
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):123-9. PubMed ID: 17643356
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.
Schwaninger AE; Meyer MR; Huestis MA; Maurer HH
J Mass Spectrom; 2011 Jul; 46(7):603-14. PubMed ID: 21656610
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective determination of 3,4-methylene-dioxymethamphetamine and two of its metabolites in human urine by cyclodextrin-modified capillary zone electrophoresis.
Lanz M; Brenneisen R; Thormann W
Electrophoresis; 1997 Jun; 18(6):1035-43. PubMed ID: 9221895
[TBL] [Abstract][Full Text] [Related]
12. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J
Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS.
Hensley D; Cody JT
J Anal Toxicol; 1999 Oct; 23(6):518-23. PubMed ID: 10517560
[TBL] [Abstract][Full Text] [Related]
14. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma.
Mueller M; Peters FT; Ricaurte GA; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):262-70. PubMed ID: 17646137
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of MDMA and its metabolites in urine by GC and GC/MS].
Shen M; Yan W; Shen B; Xiang P; Huang Z; Liu W; Bo J
Fa Yi Xue Za Zhi; 1998; 14(1):10-1, 24, 61. PubMed ID: 11360579
[TBL] [Abstract][Full Text] [Related]
16. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
Kikura R; Nakahara Y; Mieczkowski T; Tagliaro F
Forensic Sci Int; 1997 Jan; 84(1-3):165-77. PubMed ID: 9042722
[TBL] [Abstract][Full Text] [Related]
17. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma.
Steuer AE; Schmidhauser C; Liechti ME; Kraemer T
Drug Test Anal; 2015 Jul; 7(7):592-602. PubMed ID: 25371386
[TBL] [Abstract][Full Text] [Related]
19. Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection.
Ortuño J; Pizarro N; Farré M; Mas M; Segura J; Camí J; Brenneisen R; de la Torre R
J Chromatogr B Biomed Sci Appl; 1999 Feb; 723(1-2):221-32. PubMed ID: 10080649
[TBL] [Abstract][Full Text] [Related]
20. Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.
Lo Faro AF; Sprega G; Beradinelli D; Tini A; Poyatos L; Papaseit E; Berretta P; Di Giorgi A; Farre M; Takaishvili N; Farkas T; Busardò FP; Chankvetadze B
J Pharm Biomed Anal; 2024 Jan; 238():115768. PubMed ID: 37979525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
